The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

While there’s no cure for multiple sclerosis (MS), there are many treatments available. These treatments mainly focus on slowing down the progression of the disease and managing symptoms.

The FDA is adding a new boxed warning to include information that anaphylaxis can occur at any time, from as early as after ...

Multiple sclerosis (MS) is an autoimmune neurological ... your doctor will suggest different treatments to help treat symptoms and improve your quality of life. Just as the two conditions are ...

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

A new study revealed safe MS treatment options during pregnancy, reassuring women to balance effective care with their plans ...

Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics ...